Clinical Pharmacology Considerations in Pain management in Patients with Advanced Kidney Failure

June 13, 2019

Pain is common and poorlymanaged in patients with advancedCKD, likely due to both under and over prescription of appropriate analgesics.Poorlymanagedpaincontributes topatients’poorquality of lifeandexcessive healthcare use. There is tremendous variability within and between countries in prescribing patterns of analgesics, suggesting that factors other than patient characteristics account for these differences. This article discusses the pharmacologic management of acute and chronic pain in patients with advanced CKD, and the role analgesics,including opioids, play in the overall approach to pain management.

Spotlight

Gauss Surgical

Gauss Surgical, Inc. was founded in 2011 and is located in Los Altos, California. The company was started with the vision of leveraging mobile devices in the OR as medical devices, to significantly improve the quality of perioperative care. Gauss is backed by Softbank Ventures Korea, Northwell Health Ventures, LS Polaris Innovation Fund, Providence Health Ventures, Jump Capital, Promus Ventures, Summation Heath, LifeForce Ventures, Taube Investment Partners, and a group of experienced healthcare pioneers.

OTHER WHITEPAPERS
news image

How to optimize clinical supply chain management with Slope

whitePaper | January 19, 2023

Successful execution of clinical trials requires the orchestration of multiple moving parts, with everything from protocol design and patient visit schedules.

Read More
news image

Standard Consumer Scoring Tools Don’t Fit Patients

whitePaper | December 9, 2022

There’s no such thing as a “one size fits all” patient engagement strategy. Healthcare organization executives should beware— using conventional scoring tools to predict how patients will engage with and pay their healthcare bills is not an effective strategy.

Read More
news image

Personalizing Radiotherapy in Oncology: The Evolution of Treatment

whitePaper | January 9, 2020

Radiation therapy is one of the most common treatments used to fight cancer in the U.S., with more than half of cancer patients receiving it either alone or in combination with other medical interventions.1 With the traditional approach to radiation therapy, the dose and schedule is tailored to the tumor type, location, and stage of growth, but only infrequently updated in light of changes after treatment starts. Experts in adaptive therapy are looking to deliver a more personalized treatment strategy guided by the individual patient’s needs.

Read More
news image

Empower Providers to Deliver Better Experiences through Digitization

whitePaper | February 15, 2022

Healthcare providers are striving to deliver better experiences, all while dealing with a variety of interconnected pressures. But to quickly adapt to the changing world around them while delivering excellent experiences, providers must face challenges and digital solutions in a more holistic way. Streamlined healthcare workflows, connected data, and connected teams free up more time for patient care. Learn more on how ServiceNow enables innovation and operational excellence, leading to a better patient experience.

Read More
news image

Evolving a healthcare strategic partnership

whitePaper | December 21, 2022

Deepening its existing relationship with Vizient has enabled Memphis-based Baptist Memorial Health Care—a 22 hospital healthcare system in Tennessee, Mississippi and Arkansas—to develop a strategic partnership.

Read More
news image

The Rise of Hybrid Clinical Trials

whitePaper | September 21, 2022

Prior to 2020, the answer was likely not very much. Although decentralized trials (DCT) existed prior to the pandemic, COVID-19 undoubtedly had a large impact on the rapid adoption of DCT technologies.

Read More

Spotlight

Gauss Surgical

Gauss Surgical, Inc. was founded in 2011 and is located in Los Altos, California. The company was started with the vision of leveraging mobile devices in the OR as medical devices, to significantly improve the quality of perioperative care. Gauss is backed by Softbank Ventures Korea, Northwell Health Ventures, LS Polaris Innovation Fund, Providence Health Ventures, Jump Capital, Promus Ventures, Summation Heath, LifeForce Ventures, Taube Investment Partners, and a group of experienced healthcare pioneers.

Events